Characteristic | VEGF levels | IHC tissue staining of VEGF | |||
---|---|---|---|---|---|
(pg/mL) | Positive group | Negative group | |||
Median [range] | P-value | n (%) | n (%) | P-value | |
Patient | 26 | 57 | |||
Gender | |||||
Male | 314[42-1460] | 13 (50) | 39 (68) | ||
Female | 290[52-912] | 0.890 | 13 (50) | 18 (32) | 0.107 |
T stage | |||||
T1 | 313[42-1330] | 16 (65) | 48 (84) | ||
T2 | 140[50-353] | 4 (15) | 1 (2) | ||
T3 | 294[79-1460] | 6 (23) | 8 (14) | ||
T4 | - | 0.109 | 0 (0) | 0 (0) | 0.023 |
Grade | |||||
1 | 519[290-912] | 1 (4) | 6 (11) | ||
2 | 283[42-1460] | 19 (73) | 51 (89) | ||
3 | 385[225-982] | 0.024 | 6 (23) | 0 (0) | <0.001 |
UISS risk classification | |||||
Low risk | 313[42-1330] | 14 (57) | 47 (82) | ||
Intermediate risk | 282[50-1460] | 11 (42) | 10 (18) | ||
High risk | 982 | 0.282 | 1 (4) | 0 (0) | 0.014 |
Histological vein invasion | |||||
No | 325[42-1460] | 15 (58) | 38 (67) | ||
Yes | 279[79-1330] | 0.198 | 11 (42) | 19 (33) | 0.430 |
Tumor necrosis | |||||
No | 288[42-1460] | 22 (85) | 48 (84) | ||
Yes | 405[93-982] | 0.153 | 4 (15) | 9 (16) | 0.962 |
IHC staining | |||||
Grade 0 | 313 [42-968] | - | - | ||
Grade 1+ | 325 [91-511] | - | - | ||
Grade 2+ | 248 [50-1460] | - | - | ||
Grade 3+ | 507 [140-1330] | 0.378 | - | - | |
Recurrence | |||||
No | 290[42-1460] | 19 (73) | 52 (91) | ||
Yes | 478[140-982] | 0.038 | 7 (27) | 5 (9) | 0.043 |